drugset / Trial / NCT04951765

Effect of Food on the Pharmacokinetics of XZP-3287 in Healthy Subjects

NCT04951765

Phase 1 Unknown 24 enrolled Xuanzhu Biopharmaceutical Co., Ltd.
RandomizedCrossoverOpen-labelTreatment

Summary

This study will be a randomized 3-treatment, cross-over study to evaluate the bioavailability of XZP-3287 administered after a high or low-fat meal.

Timeline

Start
2021-08
Primary completion
2021-08
Completion
2021-12

Drugs

EvaluationDrugModalityDoseRoute
Subject XZP-3287 Unknown Oral

Indications

No indication recorded.